Government approves pharma policy to ensure low cost medicines
Updated: Oct 31, 2013 02:26:18pm
New Delhi, Oct 31 (KNN) Ensuring the availability of medicines at lower prices, the government has approved the Pharmaceuticals Purchase Policy (PPP), a policy for procuring medicines produced by Central Public Sector Units for a period of five years.
The policy will be applicable to 103 medicines for five years and will be consumed by central government departments, public sector undertakings and autonomous bodies.
"The Union Cabinet today approved the Pharmaceuticals Purchase Policy (PPP) for a period of five years from the date of issue of orders by the Department of Pharmaceuticals," said an official release yesterday.
The list of medicines may be reviewed and revised by the department as per requirements.
The renewal of the policy is aimed at ensuring optimum utilisation of the installed capacity of the pharma Central Public Sector Enterprises (CPSEs). It would not only provide necessary fillip in reviving these CPSEs, which are ailing but also ensure availability of quality medicines at low prices to the masses...," the release added.
The policy will also be applicable to purchase of medicines by state governments under health programmes funded by the government such as the National Rural Health Mission, it said.
The pricing of the drugs will be done by the National Pharmaceutical Pricing Authority (NPPA) using the cost-based formula as mentioned in the Drugs Price Control Order 95.
"A uniform discount of 16 per cent would be extended to all products. All the taxes, whatsoever, would have to be passed on to buyers," it said, adding that the annual revision of prices would be linked to Wholesale Price Index as per provisions contained in Drugs Prices Control Order, 2013.
The policy will extend only to CPSEs, which are under the administrative control of Department of Pharmaceuticals, such as Indian Drugs and Pharmaceuticals Ltd; Hindustan Antibiotics Ltd; Bengal Chemicals and Pharmaceuticals Ltd; Karnataka Antibiotics and Pharmaceuticals Ltd and Rajasthan Drugs and Pharmaceuticals Ltd and their subsidiaries where government owns 51 per cent or above shares.
Annual revision of prices would be linked to Wholesale Price Index as per provisions contained in Drugs Prices Control Order, 2013.
The procuring entity would purchase from pharma CPSEs and their subsidiaries subject to their meeting Good Manufacturing Practices (GMP) norms as per Schedule `M` of the Drugs & Cosmetic Rules.
In case pharma CPSEs and their subsidiaries fail to supply the medicines, the procuring entity would be at liberty to make purchases from other manufacturers. If the pharma CPSEs or their subsidiaries fail to perform as per the purchase order, they would also be subject to payment of liquidated damages or any other penalty as per the terms of the contract. (KNN/SD)
The policy will be applicable to 103 medicines for five years and will be consumed by central government departments, public sector undertakings and autonomous bodies.
"The Union Cabinet today approved the Pharmaceuticals Purchase Policy (PPP) for a period of five years from the date of issue of orders by the Department of Pharmaceuticals," said an official release yesterday.
The list of medicines may be reviewed and revised by the department as per requirements.
The renewal of the policy is aimed at ensuring optimum utilisation of the installed capacity of the pharma Central Public Sector Enterprises (CPSEs). It would not only provide necessary fillip in reviving these CPSEs, which are ailing but also ensure availability of quality medicines at low prices to the masses...," the release added.
The policy will also be applicable to purchase of medicines by state governments under health programmes funded by the government such as the National Rural Health Mission, it said.
The pricing of the drugs will be done by the National Pharmaceutical Pricing Authority (NPPA) using the cost-based formula as mentioned in the Drugs Price Control Order 95.
"A uniform discount of 16 per cent would be extended to all products. All the taxes, whatsoever, would have to be passed on to buyers," it said, adding that the annual revision of prices would be linked to Wholesale Price Index as per provisions contained in Drugs Prices Control Order, 2013.
The policy will extend only to CPSEs, which are under the administrative control of Department of Pharmaceuticals, such as Indian Drugs and Pharmaceuticals Ltd; Hindustan Antibiotics Ltd; Bengal Chemicals and Pharmaceuticals Ltd; Karnataka Antibiotics and Pharmaceuticals Ltd and Rajasthan Drugs and Pharmaceuticals Ltd and their subsidiaries where government owns 51 per cent or above shares.
Annual revision of prices would be linked to Wholesale Price Index as per provisions contained in Drugs Prices Control Order, 2013.
The procuring entity would purchase from pharma CPSEs and their subsidiaries subject to their meeting Good Manufacturing Practices (GMP) norms as per Schedule `M` of the Drugs & Cosmetic Rules.
In case pharma CPSEs and their subsidiaries fail to supply the medicines, the procuring entity would be at liberty to make purchases from other manufacturers. If the pharma CPSEs or their subsidiaries fail to perform as per the purchase order, they would also be subject to payment of liquidated damages or any other penalty as per the terms of the contract. (KNN/SD)
Loading...
